Skip to search formSkip to main contentSkip to account menu

TZP 4238

Known as: TZP-4238 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
A new synthetic steroid, 17α‐acetoxy‐chloro‐2‐oxa‐4,6‐pregnadiene‐3,20‐dione (osaterone acetate, TZP‐4238), has a potent… 
1995
1995
The effects of the new steroidal antiandrogen, TZP‐4238 on spontaneouslydeveloped canine prostatic hyperplasia (BPH) were studied… 
1994
1994
TZP-4238 is a new potent, orally active steroidal antiandrogen. Antiandrogenic activity and endocrinological profile of TZP-4238… 
1994
1994
TZP-4238, a new steroidal antiandrogen, is an orally active drug in rats and dogs. The effects of TZP-4238 on the androgen… 
1994
1994
We studied the adrenosuppressive effect of antiandrogen TZP-4238 and its metabolites. The binding affinity for the corticosteroid… 
1993
1993
The effect of a synthetic steroidal anti-androgen, TZP-4238, on steroid-induced rat prostatic hyperplasia was investigated. Male… 
1992
1992
The effects of the new steroidal antiandrogen TZP‐4238 on hormone‐induced canine prostatic hyperplasia (BPH) were studied in… 
1992
1992
The effect of a synthetic steroidal anti‐androgen, TZP‐4238, on spontaneous benign prostatic hyperplasia (BPH) in dogs was… 
1992
1990
1990
The effect of a synthetic steroidal anti‐androgen, TZP‐4238, on steroid‐induced canine prostatic hyperplasia was studied by light…